RNA polymerase II (often shortened to Pol II) is the enzyme responsible for copying protein-coding genes into messenger RNA, the molecule that carries genetic instructions from DNA to the cell’s protein-building machinery. It also transcribes many noncoding RNAs that regulate gene activity rather than coding for proteins directly.1PubMed Central. Noncoding RNAs: Regulators of the Mammalian Transcription Machinery That dual workload makes Pol II the central enzyme in eukaryotic gene expression, and its activity touches nearly every biological process, from embryonic development to immune defense to cancer.
How Pol II Is Built
Pol II is not a single protein. In yeast, crystallography has resolved a core enzyme made up of ten subunits, and in mammals the complex grows even larger with additional associated factors. The active site, where new RNA nucleotides are added to the growing chain, contains two metal ions. One stays bound permanently and positions the incoming building blocks; the other appears to cycle in and out during RNA synthesis.2PubMed. Structural basis of transcription: RNA polymerase II at 2.8 angstrom resolution Structural studies revealed that the enzyme’s architecture divides into four mobile modules, including a “clamp” that swings open to let promoter DNA enter the active center and then closes around it during transcription.
The largest subunit carries a long, flexible tail called the C-terminal domain, or CTD. In yeast this tail has 26 repeating units of a seven-amino-acid sequence; in vertebrates, including humans, the number doubles to 52 repeats.3PubMed Central. The RNA polymerase II CTD coordinates transcription and RNA processing This tail does not participate in copying DNA into RNA. Instead, it acts as a landing pad for dozens of other proteins that process the new RNA, repair damaged DNA, and remodel the surrounding chromatin. The CTD turns out to be one of the most heavily decorated structures in the cell, and its modifications change as Pol II moves along a gene.
Getting Started at a Promoter
Pol II cannot find a gene’s start site on its own. It relies on a group of helper proteins called general transcription factors (abbreviated GTFs) to locate the promoter and pry open the DNA double helix. Together, these proteins assemble into what researchers call a pre-initiation complex, or PIC, which can contain over 30 individual protein subunits. Cryo-electron microscopy studies have shown a striking arrangement: in the PIC, the promoter DNA is held entirely by the general transcription factors and does not touch Pol II at all. The DNA is essentially suspended above the enzyme’s cleft, kept away from the polymerase until conditions are right to begin transcription.4PubMed Central. Architecture of an RNA polymerase II transcription pre-initiation complex
The DNA in this arrangement is bent sharply at several points downstream of the TATA box, a common promoter element. Higher-resolution imaging confirmed that the DNA at the downstream end of the PIC overlaps with the position DNA occupies inside a polymerase that is already transcribing, hinting at how the transition from “ready” to “go” happens mechanically.5PubMed Central. Structure of an RNA polymerase II preinitiation complex
The CTD as a Coordination Hub
Once Pol II starts moving along a gene, the CTD undergoes a wave of chemical modifications, mostly phosphorylation of different amino acids in its repeating unit. Each position can be phosphorylated independently, and the pattern changes as the polymerase progresses from the promoter through the gene body to the termination zone. For example, one position (serine-5) is phosphorylated early, near the start site, while another (serine-2) accumulates later during elongation. A third modification, phosphorylation of tyrosine-1, rises after the transcription start site and drops before the polyadenylation signal at the gene’s end, keeping termination factors away from the main body of the gene.6PubMed. CTD tyrosine phosphorylation impairs termination factor recruitment to RNA polymerase II
These shifting phosphorylation marks serve as timed invitations for different processing complexes, from capping enzymes to splicing machinery to termination factors. The CTD essentially lets the cell run multiple assembly lines at once: while Pol II copies DNA into RNA, the freshly made RNA is simultaneously being modified and prepared for export. The disruption of this delicate balance of kinases and phosphatases is increasingly linked to developmental disorders, neurodegeneration, and cancer.7PubMed Central. RNA polymerase II phosphorylation dynamics: from molecular mechanisms to human disease
Pausing Right After the Start
In multicellular organisms, Pol II frequently pauses about 30 to 60 nucleotides downstream of the transcription start site. This “promoter-proximal pausing” is not a glitch. It is a deliberate regulatory step, stabilized by two elongation factors called DSIF and NELF.8Journal of Molecular Biology. Pause Patrol: Negative Elongation Factor’s Role in Promoter-Proximal Pausing and Beyond The paused polymerase sits on the gene like a runner in the blocks, ready to sprint the moment a signal arrives.
Recent cryo-EM work has resolved what NELF actually looks like on the polymerase surface in this state. Two distinct conformations were captured: a paused state, matching earlier structures, and a newly described “poised” state where NELF rearranges on Pol II in a way that allows the proofreading factor TFIIS to reactivate the enzyme and extend the RNA chain. Researchers also identified a conserved surface on one Pol II subunit that appears to serve as a mutually exclusive docking site for initiation factors, pausing factors, and elongation factors, meaning the polymerase can only be occupied by one set of regulators at a time.9Molecular Cell. Structural basis of transcription elongation and pausing by RNA polymerase II This toggle-switch design helps explain how a single enzyme can be repurposed at each stage of the transcription cycle.
Capping and Splicing on the Fly
One of Pol II’s distinguishing tricks is that it coordinates RNA processing while still transcribing. Within seconds of the RNA emerging from the enzyme, a capping enzyme is recruited to the CTD by the early serine-5 phosphorylation mark. This enzyme adds a protective chemical cap to the RNA’s front end, shielding it from degradation and later helping ribosomes recognize it for translation.10PubMed Central. Functional interactions of RNA-capping enzyme with factors that positively and negatively regulate promoter escape by RNA polymerase II In yeast, the physical contact between the capping complex and the phosphorylated CTD has been confirmed to be required for efficient cap formation.11Scientific Reports. The mRNA capping enzyme of Saccharomyces cerevisiae has dual specificity to interact with CTD of RNA Polymerase II
Splicing, the removal of non-coding intron sequences from the pre-mRNA, also happens while Pol II is still at work. The splicing machinery assembles on the emerging RNA co-transcriptionally, and this coupling has been linked to specific CTD phosphorylation patterns, adding another layer to the coordination code.12PubMed. Co-transcriptional splicing and the CTD code Interestingly, live-cell measurements of polymerase speed on model genes found that the presence of active splicing upstream did not slow down Pol II elongation, suggesting the spliceosome rides along without acting as a physical brake on the enzyme.13PLOS Biology. The In Vivo Kinetics of RNA Polymerase II Elongation during Co-Splicing
Navigating Chromatin
In a living cell, DNA is not bare. It is wrapped around histone proteins into repeating units called nucleosomes, which create a significant physical obstacle for an advancing polymerase. Pol II can push through a nucleosome, but not easily: the strongest barrier tends to occur at the central point, or dyad, of the histone-wrapped DNA.
To deal with this, cells employ histone chaperone complexes. One of the best studied is FACT, which travels along with elongating Pol II on active genes.14PubMed Central. The FACT complex travels with elongating RNA polymerase II and is important for the fidelity of transcriptional initiation in vivo In vitro experiments showed that FACT stimulates transcription through nucleosomes specifically by lowering the barrier at the dyad, though it does not release a paused polymerase at the nucleosome entry site.15Molecular Cell. FACT maintains +1 nucleosome integrity, which stabilizes promoter-proximal pausing Another factor, the chromatin remodeler Chd1, also assists Pol II through nucleosomes. Structural work showed that Chd1 and FACT cannot bind the nucleosome simultaneously in their stable states, but Chd1 can remain loosely tethered through a flexible region while FACT takes its turn, and vice versa.16Nature Structural & Molecular Biology. Structural basis of nucleosome transcription mediated by Chd1 and FACT This tag-team approach likely keeps transcription moving through densely packed chromatin without permanently evicting histones, which would scramble the cell’s gene-regulation marks.
How Transcription Ends
Stopping is not as simple as the polymerase falling off the DNA at the end of a gene. In humans, Pol II typically runs past the polyadenylation signal, the sequence that marks where the mature mRNA’s tail will be added. A cleavage complex cuts the RNA at that signal, which creates a free, unprotected end on the RNA still attached to the polymerase. An exonuclease called XRN2 then chews this leftover RNA in a 5′-to-3′ direction, catching up to Pol II and dislodging it from the DNA, a process dubbed the “torpedo” mechanism.17Molecular Cell. Kinetic Competition between RNA Polymerase II Elongation and Xrn2 Exonuclease Dictates Transcription Termination Speeds
Evidence now points to a combined model in which Pol II also slows down over the termination region, making it easier for XRN2 to catch up. This slowdown appears to depend on a phosphatase called PP1, and the cleavage complex provides both the entry site for XRN2 and upstream conformational changes to the elongation complex.18PubMed Central. A unified allosteric/torpedo mechanism for transcriptional termination on human protein-coding genes When XRN2’s nuclease activity is experimentally inactivated, Pol II does not stop on time, and its occupancy extends thousands of base pairs past the normal termination zone, confirming the enzyme’s central role.
Error Correction During Transcription
Unlike the DNA replication machinery, Pol II does not have a dedicated proofreading subunit. But it is not blind to mistakes. When a wrong nucleotide is incorporated, the polymerase tends to stall and slide backward along the DNA, a process called backtracking. The mismatched nucleotide at the end of the RNA is pushed into a secondary channel on the enzyme, where a cleavage factor called TFIIS can cut it off, allowing the polymerase to try again. Experiments showed that pauses triggered by misincorporated nucleotides led to backtracking even when an external force was pulling the polymerase forward, and TFIIS shortened the duration of these pauses, especially when working alongside another factor, TFIIF.19PubMed Central. Transcription factors TFIIF and TFIIS promote transcript elongation by RNA polymerase II by synergistic and independent mechanisms This gives Pol II a limited but meaningful proofreading capacity, reducing the error rate of transcription beyond what the enzyme’s selectivity alone would achieve.
The Mediator and Enhancer Connections
Pol II is not regulated solely by factors sitting at the promoter. In complex organisms, genes are often activated by distant regulatory sequences called enhancers, which can sit tens or even hundreds of thousands of base pairs away from the gene they control. The link between enhancers and Pol II runs through a massive multi-protein assembly called the Mediator complex. Mediator connects sequence-specific transcription factors bound at enhancers to the general transcription machinery at the promoter, acting as a kind of switchboard for gene activation. It can facilitate this connection through chromatin loops that physically bring the enhancer and promoter into contact, and possibly through the formation of concentrated molecular hubs at active genes.20PubMed Central. The Mediator complex as a master regulator of transcription by RNA polymerase II
When Mediator is experimentally depleted from cells, the frequency of enhancer-promoter interactions drops measurably, with an average reduction of about a third at the strongest Mediator binding sites. The functional consequence is severe: gene expression at affected genes falls by an average of roughly sevenfold.21Nature Structural & Molecular Biology. The Mediator complex regulates enhancer-promoter interactions The CTD itself participates in Mediator recruitment. Multivalent interactions involving tyrosine residues in the CTD drive it to undergo phase separation, forming condensed droplets in vitro, and these same interactions are responsible for co-recruiting Mediator to the CTD during that process.22Nature Communications. Driving forces behind phase separation of the carboxy-terminal domain of RNA polymerase II
When Pol II Meets DNA Damage
Because Pol II scans the template strand of every active gene, it is one of the cell’s most sensitive damage detectors. When the enzyme runs into a lesion in the DNA, such as one caused by ultraviolet light or certain chemicals, it stalls. This stalling triggers a specialized DNA repair pathway called transcription-coupled nucleotide excision repair, which prioritizes fixing damage on actively transcribed genes.23Nature Reviews Molecular Cell Biology. Transcription-coupled DNA repair: two decades of progress and surprises
In cells with a working repair system, the stalled Pol II is resolved quickly, the damage is removed, and transcription resumes. But in cells lacking the repair factors CSA or CSB, the polymerase stays stuck on the lesion. Live-cell imaging has shown that this damage-bound Pol II blocks other DNA processes and shields the lesion from alternative repair pathways, compounding the problem.24PubMed Central. Differential processing of RNA polymerase II at DNA damage correlates with transcription-coupled repair syndrome severity Mutations in CSA or CSB cause Cockayne syndrome, a severe developmental and neurological disorder. The disease underscores a somewhat counterintuitive point: Pol II’s sensitivity to DNA damage is normally a feature, not a bug, but only when the rest of the repair machinery can clear the jam.
Disease Links and Drug Targets
Pol II dysfunction surfaces in human disease in several ways. One striking example is CCFDN syndrome (congenital cataracts facial dysmorphism neuropathy), an autosomal recessive disorder caused by a mutation in the gene encoding FCP1, a phosphatase that dephosphorylates the Pol II CTD. A single nucleotide substitution creates an aberrant splice, and the resulting partial loss of FCP1 activity disrupts the transcription cycle broadly enough to cause cataracts, facial abnormalities, and peripheral neuropathy. This was identified as the first “purely” transcriptional defect affecting Pol II-mediated gene expression.25Nature Genetics. Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome
On the therapeutic side, because many cancers depend on abnormally high levels of transcription, inhibitors targeting the general Pol II transcription machinery have attracted interest as candidate cancer drugs.26PubMed Central. Therapeutic Targeting of the General RNA Polymerase II Transcription Machinery Several compounds in development interfere with the kinases that phosphorylate the CTD, blocking the enzyme from progressing through its transcription cycle. The challenge is selectivity: since every cell in the body uses Pol II, shutting it down indiscriminately would be toxic. Research is focused on exploiting the fact that certain tumor types are disproportionately reliant on specific transcriptional programs, making them more vulnerable to partial Pol II inhibition than healthy cells.
Natural Poisons That Target Pol II
The most famous Pol II inhibitor comes from the death cap mushroom. Alpha-amanitin, the toxin responsible for most fatal mushroom poisonings worldwide, binds directly to Pol II and jams its translocation mechanism. Crystal structures of the enzyme bound to the toxin revealed that alpha-amanitin traps two functional elements, the trigger loop and the bridge helix, in a conformation between the pre- and post-translocation states. The trigger loop, which normally swings through open, wedged, and closed positions during each nucleotide addition cycle, gets locked in place, blocking both the incorporation of new nucleotides and the forward movement of the enzyme along DNA.27Nature Structural & Molecular Biology. Structural basis of transcription inhibition by α-amanitin and implications for RNA polymerase II translocation The toxin’s potency reflects how essential Pol II function is: shut it down, and cells simply cannot make the messenger RNAs they need to survive. The liver and kidneys, which are metabolically active organs with high transcriptional demand, fail first.
How Pol II Compares to the Cell’s Other RNA Polymerases
Eukaryotic cells have at least three nuclear RNA polymerases. RNA polymerase I transcribes ribosomal RNA genes, producing the structural RNA of ribosomes. RNA polymerase III transcribes a different set of small, highly expressed RNAs, including transfer RNAs and 5S ribosomal RNA. Early biochemical work established that all three enzymes share some low-molecular-weight subunits but differ in their large subunits and in several class-specific components.28PubMed Central. Distinct molecular structures of nuclear class I, II, and III DNA-dependent RNA polymerases
The key difference between Pol II and its siblings is regulatory flexibility. Pol III, for example, transcribes a relatively limited set of genes with similar promoter structures and stable initiation complexes that allow rapid recycling. Pol II, by contrast, handles a vast and diverse repertoire of genes with wildly different promoters and a constantly shifting cast of regulatory factors.29PubMed Central. Comparative overview of RNA polymerase II and III transcription cycles, with focus on RNA polymerase III termination and reinitiation The CTD, exclusive to Pol II, is the structural innovation that makes this versatility possible, serving as the coordination platform for the dozens of factors that fine-tune each step.
Plants add another layer of complexity by having evolved two additional nuclear RNA polymerases, Pol IV and Pol V, which descended from Pol II. These plant-specific enzymes do not make messenger RNA. Instead, they play nonredundant roles in producing small interfering RNAs and guiding DNA methylation, a form of gene silencing. Pol IV generates the initial small RNA precursors, while Pol V produces scaffold transcripts at the target sites where silencing occurs.30Molecular Cell. Distinct and Shared Subunit Compositions of Plant RNA Polymerases IV and V and Evolution of a Variant RNA Polymerase II Their existence shows that the Pol II architecture was flexible enough to be repurposed, through gene duplication and divergence, for entirely new biological functions.
How Viruses Exploit Pol II
Some viruses have found ways to hijack or neutralize the host’s Pol II machinery. Influenza virus provides a particularly well-studied case. Its own RNA polymerase physically associates with the host’s Pol II, and during infection, the large subunit of Pol II is ubiquitinated and degraded through the proteasome pathway. Expression of the viral polymerase alone is enough to trigger this degradation and to inhibit Pol II transcription. The likely purpose is strategic: by shutting down host transcription, the virus suppresses the production of antiviral proteins, giving itself a window to replicate.31PubMed Central. Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells This also helps explain why influenza can be so damaging to tissue: it does not just redirect the cell’s resources, it actively destroys the host’s transcription engine.